UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiviral drug discovery: preparing for the next pandemic

Chemical Society reviews, 2021-03, Vol.5 (6), p.3647-3655

2021

Volltextzugriff (PDF)

Far-UVC (222 nm) efficiently inactivates an airborne pathogen in a room-sized chamber

Scientific reports, 2022-03, Vol.12 (1), p.4373-9, Article 4373

2022

Volltextzugriff (PDF)

Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function

Viruses, 2020-01, Vol.12 (1), p.110

2020

Volltextzugriff (PDF)

Antiviral Agents: Discovery to Resistance

Viruses, 2020-04, Vol.12 (4), p.406

Adamson, Catherine S

2020

Volltextzugriff (PDF)

Inhibitors of the interferon response enhance virus replication in vitro

PloS one, 2014-11, Vol.9 (11), p.e112014-e112014

2014

Volltextzugriff (PDF)

Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat

Retrovirology, 2010-04, Vol.7 (1), p.36-36, Article 36

2010

Volltextzugriff (PDF)

HIV-1 Maturation Inhibitor Bevirimat Stabilizes the Immature Gag Lattice

Journal of Virology, 2011-02, Vol.85 (4), p.1420-1428

2011

Volltextzugriff (PDF)

Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector

Nucleic acids research, 2021-12, Vol.49 (22), p.13122-13134

2021

Volltextzugriff (PDF)

In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat)

Journal of Virology, 2006-11, Vol.80 (22), p.10957-10971

2006

Volltextzugriff (PDF)

Virus maturation as a new HIV-1 therapeutic target

Expert opinion on therapeutic targets, 2009-08, Vol.13 (8), p.895-908

2009

Volltextzugriff (PDF)

Impact of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457)

Journal of Virology, 2009-05, Vol.83 (10), p.4884-4894

2009

Volltextzugriff (PDF)

The role of ion dissolution in metal and metal oxide surface inactivation of SARS-CoV-2

Applied and environmental microbiology, 2024-02, Vol.90 (2), p.e0155323-e0155323

2024

Volltextzugriff (PDF)

Novel approaches to inhibiting HIV-1 replication

Antiviral research, 2010-01, Vol.85 (1), p.119-141

2010

Volltextzugriff (PDF)

Molecular Characterization of Feline Immunodeficiency Virus Budding

Journal of Virology, 2008-03, Vol.82 (5), p.2106-2119

2008

Volltextzugriff (PDF)

Correction: Antiviral drug discovery: preparing for the next pandemic

Chemical Society reviews, 2021-08, Vol.5 (16), p.9346-9346

2021

Volltextzugriff (PDF)

The molecular basis of HIV capsid assembly-five years of progress

Reviews in medical virology, 2004-03, Vol.14 (2), p.107-121

2004

Volltextzugriff (PDF)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process

Molecular Biology International, 2012-01, Vol.2012 (2012), p.195-207

2012

Volltextzugriff (PDF)

Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat

Retrovirology, 2010-04, Vol.7, p.36

2010

Volltextzugriff (PDF)

Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396

Journal of virology, 2016-09, Vol.90 (18), p.8181-8197

2016

Volltextzugriff (PDF)

Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice

Antiviral research, 2018-02, Vol.150, p.79-92

2018

Volltextzugriff (PDF)

Anti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets

Molecular interventions, 2009-04, Vol.9 (2), p.70-74

2009

Volltextzugriff (PDF)

Identification of Novel Inhibitors of the Type I Interferon Induction Pathway Using Cell-Based High-Throughput Screening

Journal of biomolecular screening, 2016-10, Vol.21 (9), p.978-988

2016

Volltextzugriff (PDF)

Green fluorescent protein as a reporter of prion protein folding

Virology journal, 2006-08, Vol.3 (1), p.59-59, Article 59

2006

Volltextzugriff (PDF)

Recent progress in antiretrovirals – lessons from resistance

Drug discovery today, 2008-05, Vol.13 (9), p.424-432

2008

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Assembly, Release, and Maturation

Advances in Pharmacology, 2007, Vol.55, p.347-387

2007

Volltextzugriff (PDF)

1 – 25 von 207

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Englisch
(207)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Fertility And Sterility
(12)
Journal Of Virology
(7)
Bmj Open
(6)
Virology
(6)
Health Technology Assessment
(5)
Plos One
(5)
Trials
(5)
Alzheimer's & Dementia
(4)
Current Controlled Trials In Cardiovascular Medicine
(4)
Inorganic Chemistry
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antiviral drug discovery: preparing for the next pandemic

Far-UVC (222 nm) efficiently inactivates an airborne pathogen in a room-sized chamber

Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function

Antiviral Agents: Discovery to Resistance

Inhibitors of the interferon response enhance virus replication in vitro

Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat

HIV-1 Maturation Inhibitor Bevirimat Stabilizes the Immature Gag Lattice

Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector

In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat)

Virus maturation as a new HIV-1 therapeutic target

Impact of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457)

The role of ion dissolution in metal and metal oxide surface inactivation of SARS-CoV-2

Novel approaches to inhibiting HIV-1 replication

Molecular Characterization of Feline Immunodeficiency Virus Budding

Correction: Antiviral drug discovery: preparing for the next pandemic

The molecular basis of HIV capsid assembly-five years of progress

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process

Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat

Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396

Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice

Anti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets

Identification of Novel Inhibitors of the Type I Interferon Induction Pathway Using Cell-Based High-Throughput Screening

Green fluorescent protein as a reporter of prion protein folding

Recent progress in antiretrovirals – lessons from resistance

Human Immunodeficiency Virus Type 1 Assembly, Release, and Maturation

Suchergebnisse filtern